SuperGen to Present at 7th Annual BIO Investor Forum on October 29, 2008
SuperGen's presentation at the BIO Investor Forum is scheduled to begin at4:15 p.m. PDT (7:15 p.m. EDT). A live webcast of the presentation will beavailable on the investor relations section of the Company's Web site atwww.supergen.com. A webcast replay of the presentation will be availableshortly following the live event.
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery and development of novel cancer therapies. SuperGenis developing a number of therapeutic anticancer products focused on kinaseand cell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit http://www.supergen.com.Contacts: SuperGen, Inc. Dorland Global Public Relations Timothy L. Enns Michael Beckerich (Media) SVP, Corporate Communications Tel: (212) 677-7632 & Business Development firstname.lastname@example.org Tel: (925) 560-0100 Email: email@example.com Mary M. Vegh Manager, Investor Relations Tel: (925) 560-2845 E-mail: firstname.lastname@example.org
SOURCE SuperGen, Inc.
You May Also Like